Baralgetas - anesthetic.  Baralgetas tablets

Pharmacological action

Baralgetas - a combined drug relieves pain and spasms.

The active ingredients of the drug - metamizol sodium hydrochloride pitofenone bromide fenpiveriniya.

Metamizole has antipyretic and analgesic effect, fenpiveriniya bromide pitofenone hydrochloride relaxes the smooth muscles of internal organs. Action pitofenone hydrochloride similar to the effect of papaverine.

Product form

Baralgetas release tablets, solution for intramuscular injections, intravenous infusions.

Indications Baralgetasa

Baralgetas of instruction prescribed for moderate and weak pain caused by spasms of the muscles of internal organs: spasms of the bladder and ureter, renal, gastrointestinal and biliary colic.

Application Baralgetasa also effective when biliary dyskinesia, chronic colitis, algodismenoree, postcholecystectomy syndrome, diseases of the pelvic organs.

Reviews Baralgetase also indicate that the drug can be used in a short treatment of myalgia, sciatica, arthralgia, neuralgia, as a painkiller after operations and diagnostic procedures.

Dosing instructions for Baralgetasa

Tablets Baralgetas teenagers after 15L, adult appointed to take 1-2 pills 2-3r / day. Children 12-14 years old are allowed to take one tablet Baralgetasa at one time, no more than 6 Table / day; Children 8-11 years are designated to take on 0, 5 pills at a time, not more than 4 tablets / day; children 5-7 years - and 0, 5 tablets, no more than 2 tablets / day.

Intravenous drug is administered to adolescents after 15L, adults with severe and acute colic - in the amount of 2 ml. Enter Baralgetas shown slowly, 1 ml for 1 minute. If necessary, medication can enter again - through 6-8ch.

Baralgetas intramuscularly administered 2-3 p / day - 2-5ml. Acceptable daily intake - 10ml. The treatment lasts for 5 days.

According to the instructions Baralgetas can be administered intramuscularly and intravenously for children: aged 3-11mes - in the amount of 0, 1-0, 2 ml intramuscular injection only; children 1-2l - 0, 2-0, 3 ml intramuscular or 0, 1-0, 2 ml intravenously; children 3-4L - 0, 3-0, 4 ml intramuscular or 0, 2-0, 3 ml intravenously; children 5-7l - 0, 4-0, 5 mL intramuscularly or 0, 3-0, 4 ml intravenously; children 8-12l - 0, 6-0, 7 mL intramuscularly or 0, 5-0, 6 ml intravenously; children 12-15l - 0 8-1ml intramuscularly or intravenously.

Before the introduction of a vial of the drug should be hold in the hand to warm the solution.  Baralgetas tablets

side effects

Baralgetas can cause allergies: urticaria, angioneurotic edema, erythema, necrolysis, bronchospasm, anaphylactic shock.

Application Baralgetasa in some cases, provokes renal dysfunction, anuria, proteinuria, oliguria, jade, discoloration of urine, reducing the pressure, leucopenia, agranulocytosis, thrombocytopenia.

There are reviews of Baralgetase, causing dry mouth, worsening sweating, urination, tachycardia, infiltration at the injection site.

In case of overdose there is vomiting, drowsiness, nausea, epigastric pain, pressure reduction, impaired renal and hepatic function, seizures. In these cases, patients are washed stomach give drink charcoal.

Contraindications Baralgetasa

Baralgetas of instructions are not prescribed for the oppression of bone marrow hematopoietic function, serious kidney and liver failure, tachyarrhythmia, angina, decompensated chronic heart failure, glaucoma closure, prostatic hyperplasia, intestinal obstruction, collapse, hypersensitivity, pregnancy, lactation.

Intravenous drug is not administered to children under 3 months or weighing less than 5kg. Tablets Baralgetas contraindicated in children under 5 years old.

Reviews Baralgetase suggest that caution should be taken in the kidney and liver failure, asthma, tendency to low blood pressure, anti-hypersensitivity to non-steroidal drugs.